Nephrocare Health Services Ltd

Nephrocare Health Services Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Nephrocare Health Services Ltd achieved a significant milestone on 12 June 2026, reaching a new 52-week high of Rs.767.95. This marks the highest price level the stock has attained in the past year, reflecting sustained momentum amid a mixed market backdrop.

After opening with a 2.01% gap up, Nephrocare Health Services Ltd touched a fresh all-time high of Rs 767.95 on 12 Jun 2026, marking a significant milestone in its recent rally despite a slight intraday pullback.

With a decisive surge to Rs 760.85 on 11 Jun 2026, Nephrocare Health Services Ltd has reached a fresh 52-week and all-time high, marking a significant milestone in its price momentum. This rally unfolds amid a broader market environment where the Sensex is retreating, underscoring the stock's relative strength and technical resilience.

Nephrocare Health Services Ltd has reached a significant milestone by touching an all-time high price of Rs 760.50 on 11 June 2026, marking a remarkable phase in the company’s market journey within the healthcare services sector.

Nephrocare Health Services Ltd achieved a significant milestone on 10 June 2026, as its stock price surged to an all-time high of Rs.725.85. This marks a notable advancement for the healthcare services company, reflecting strong market performance and sustained investor confidence over recent periods.

With a decisive surge to Rs 725.15 on 10 Jun 2026, Nephrocare Health Services Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum.

The Sensex edged up 0.62% on 09 Jun 2026, but Nephrocare Health Services Ltd outpaced the broader market with an 8.36% gain, touching a fresh 52-week and all-time high of Rs 715.7. This 5.54 percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

With a decisive intraday surge to Rs 694.9 on 09 Jun 2026, Nephrocare Health Services Ltd has reached a fresh 52-week and all-time high, propelled by a strong alignment of technical indicators and sustained price momentum.

Extending its recent rally, Nephrocare Health Services Ltd surged 4.51% on 9 Jun 2026 to close at Rs 694.35, marking a fresh all-time high just 0.54% above its 52-week peak. This advance outpaced the Sensex, which gained a modest 0.34% on the day, underscoring the stock's strong relative momentum.

With a sustained six-day rally culminating in a fresh 52-week high of Rs 690.65 on 8 Jun 2026, Nephrocare Health Services Ltd has demonstrated remarkable price momentum, outpacing the broader market's subdued performance over the past year.

Nephrocare Health Services Ltd has reached a significant milestone by touching its all-time high price of ₹686.00 on 08 Jun 2026, marking a notable achievement in the healthcare services sector. This surge reflects a sustained period of robust gains and positive market sentiment surrounding the company’s performance.

With a decisive surge to Rs 670.4 on 3 Jun 2026, Nephrocare Health Services Ltd has reached a fresh 52-week and all-time high, marking a significant milestone in its price momentum despite a broadly weaker market backdrop.

After a sustained rally that has outpaced the broader market by a wide margin, Nephrocare Health Services Ltd touched a fresh all-time high of Rs 670.40 on 3 June 2026, marking a significant milestone for the small-cap healthcare services company.

Nephrocare Health Services Ltd has seen its investment rating upgraded from Sell to Hold as of 2 June 2026, reflecting a notable improvement in its technical outlook and sustained financial performance. The healthcare services company, classified as a small-cap with a Market Mojo score of 57.0, has demonstrated positive momentum across key parameters including quality, valuation, financial trends, and technical indicators, prompting a reassessment of its market stance.

Nephrocare Health Services Ltd has demonstrated a significant shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, supported by key technical indicators and a notable upgrade in its Mojo Grade from Sell to Hold. This development comes amid strong price performance and improving market sentiment, signalling potential opportunities for investors in the healthcare services sector.

Surging to an intraday peak of Rs 663 on 2 Jun 2026, Nephrocare Health Services Ltd has marked a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaced its sector and the broader market.